Swansea University Medical School has appointed two key members of staff as it prepares
to launch its new pharmacy course.
Mair Davies, immediate past-Director for Wales for the Royal Pharmaceutical Society, and
Dr Neil Hartman, head of nuclear medicine at Singleton Hospital, have both been given
Honorary Professor appointments ahead of the new MPharm degree beginning in 2021.
Head of Pharmacy Professor Andrew Morris said: “I am very pleased to have the support
of two such eminent individuals within the profession to help advise our course
developments.”
He emphasised that the current crisis had demonstrated the important role that pharmacists
play in the fight against Covid-19 and just why the profession is so crucial to healthcare.
“Pharmacy ensures the public has access to medicines and healthcare advice. This
has always been an important role, but it has proven critical during the pandemic.
“In future the health service in Wales will continue to place a greater emphasis on
preventing illness, on supporting people to manage their own health and wellbeing,
and on enabling people to live independently for as long as they can – the
pharmacists we will be training here in Swansea will be a crucial part of this.”
During Mair Davies’s four years as RPS Director for Wales there were considerable
developments in the profession culminating in the release of the Pharmacy: Delivering a
Healthier Wales vision document.
She said: “It is a pleasure to join Swansea University and I look forward to working
with the Pharmacy Team and wider stakeholders to help develop an innovative new
pharmacy programme.”
Dr Hartman joined Singleton in 2018 from St Bartholomew’s Hospital where he was head of
radiopharmacy. He previously held affiliate academic appointments at Cambridge University,
Queen Mary University of London and Purdue University.
Swansea Bay University Health Board radiopharmacy manufactures radiopharmaceuticals
for all the local nuclear medicine departments to ensure diagnostic services remain
uninterrupted during the pandemic.
Dr Hartman said: “I am thrilled to receive this appointment which enables me to
continue my involvement in pharmacy education and contribute to the development
of the next generation of radiopharmacists.
He added that he sees his new role as four-fold:
To aid the new pharmacy school in establishing an exciting curriculum;
To teach aspiring pharmacists about the design, pharmaceutics and
pharmacokinetics of diagnostic medicines in radiology and nuclear medicine;
To recruit graduate students to aid and enhance our knowledge and application of
novel radiopharmaceuticals; and,
To provide a facility (at the Singleton Hospital) for pharmacy students (from Swansea
University and further afield) to get shadowing experience in radiopharmacy.
Find out more about the new course by attending our next Virtual Open Day on June 20th
Add Comment